Organon (OGN) EBITDA Margin (2020 - 2026)
Organon (OGN) posted quarterly EBITDA Margin of 16.1% for Q1 2026, up 30.0% year-over-year from 12.38% in Q1 2025, and up 15.51% on a QoQ basis from 13.93% in Q4 2025.
Organon (OGN) EBITDA Margin (2020 - 2026) Analysis & Trends
Organon (OGN) has reported EBITDA Margin for 7 consecutive years, with 16.1% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 30.0% year-over-year to 16.1%; the TTM figure through Mar 2026 stood at 18.29% (down 275.0% YoY), while the FY2025 annual figure was 18.19%, up 1556.0% from the prior year.
- EBITDA Margin came in at 16.1% for Q1 2026 at Organon, up from 13.93% in the prior quarter.
- The five-year high for EBITDA Margin was 25.98% in Q3 2024, with the low at 36.23% in Q4 2023.
- Average EBITDA Margin over 5 years is 3.77%, with a median of 7.59% recorded in 2022.
- Across the five-year window, EBITDA Margin plunged 1752 bps in 2023 and soared 6100 bps in 2024, its largest moves.
- Year by year, EBITDA Margin stood at 32.53% in 2022, then retreated by 11 bps to 36.23% in 2023, then surged by 150 bps to 18.09% in 2024, then decreased by 23 bps to 13.93% in 2025, then rose by 16 bps to 16.1% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 16.1%, 13.93%, and 22.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 47.98% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 26.44% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 26.60% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 18.85% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -286.83% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn | 16.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.10% |
| Dec 31, 2025 | 13.93% |
| Sep 30, 2025 | 22.35% |
| Jun 30, 2025 | 20.33% |
| Mar 31, 2025 | 15.80% |
| Dec 31, 2024 | 18.09% |
| Sep 30, 2024 | 25.98% |
| Jun 30, 2024 | 24.02% |
| Mar 31, 2024 | -26.45% |
| Dec 31, 2023 | -36.23% |
| Sep 30, 2023 | -35.02% |
| Jun 30, 2023 | -24.00% |
| Mar 31, 2023 | -22.43% |
| Dec 31, 2022 | -32.53% |
| Sep 30, 2022 | -17.50% |
| Jun 30, 2022 | -18.99% |
| Mar 31, 2022 | -7.59% |
| Dec 31, 2021 | -22.65% |
| Sep 30, 2021 | -13.75% |
| Jun 30, 2021 | -9.15% |